quinuclidines has been researched along with verapamil in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hosoi, Y; Kanamaru, T; Konno, T; Nakagami, H; Tajiri, S; Yada, S; Yoshida, K | 1 |
| Crater, G; Hughes, S; Kelleher, D; Mehta, R; Preece, A | 1 |
1 trial(s) available for quinuclidines and verapamil
| Article | Year |
|---|---|
Effect of verapamil on systemic exposure and safety of umeclidinium and vilanterol: a randomized and open-label study.
Topics: Administration, Oral; Adolescent; Adrenergic beta-2 Receptor Agonists; Adult; Aged; Benzyl Alcohols; Chlorobenzenes; Drug Combinations; Dry Powder Inhalers; Female; Heart Rate; Humans; Male; Middle Aged; Muscarinic Antagonists; Potassium; Pulmonary Disease, Chronic Obstructive; Quinuclidines; Vasodilator Agents; Verapamil; Young Adult | 2013 |
1 other study(ies) available for quinuclidines and verapamil
| Article | Year |
|---|---|
The relationship between the drug concentration profiles in plasma and the drug doses in the colon.
Topics: Administration, Oral; Animals; Anti-Allergic Agents; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Area Under Curve; Biological Availability; Colon; Delayed-Action Preparations; Diclofenac; Diltiazem; Dogs; Dose-Response Relationship, Drug; Hypoglycemic Agents; Metformin; Muscarinic Agonists; Quinuclidines; Terfenadine; Thiophenes; Verapamil | 2010 |